Breast Cancer Research
Breast Cancer Research - most related articles:
-
Breast cancer drug Tykerb to be subsidised - 5.3
-
Breastfeeding mothers reduce breast cancer risk - 5
-
Breast cancer recurrence high in women with dense breasts - 4.9
-
Exercise reduces breast cancer risk - 4.8
-
7% breast cancer patients have breast reconstruction surgery - 4.8
-
Breast stem cell fate is regulated by notch - 4.8
-
Body fat distribution linked to ER negative breast cancer - 4.7
-
Coffee may reduce breast cancer risk - 4.7
-
Cleaning products may cause breast cancer - 4.6
-
BRCA mutation increases breast cancer risk in opposite breast - 4.6
Breast Cancer Research articles
Moderate weight loss reduces breast cancer riskEven a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, revealed by researchers at Fred Hutchinson Cancer Research Center.
Long term hormone therapy linked to higher breast cancer riskLong-term use of estrogen plus progesterone and estrogen-only hormone therapy is linked with a higher risk for developing breast cancer. Researchers found this breast cancer risk was 88 percent higher.
Red wine drinking may reduce breast cancer risk in womenA glass of red wine with dinner may reduce breast cancer risk in women.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
HER growth proteins do not predict outcome of herceptin treatment breast cancer patientsPrecisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2 Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.
$3.5 million Komen award to study rare and aggressive type of breast cancerThe Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.
Many advanced breast cancer patients do not receive recommended treatmentForty-five percent of women with advanced breast cancer in the U.S. did not receive postmastectomy radiation therapy (PMRT) despite the publication of evidence-based guidelines outlining PMRT as a potentially lifesaving treatment, according to new research from The University of Texas MD Anderson Cancer Center. The study, published in the July issue of Cancer, found that PMRT use rates for women with advanced breast cancer have remained static since 1999.
Pfizer drug reduces breast cancer in high risk womenThe drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of an international, randomized double-blind phase III clinical trial in which University at Buffalo researchers and hundreds of Western New York women played a critical role, revealed at the American Society of Clinical Oncology annual meeting.
How breast cancer cells adapt to environmental stressAn international research team led by Dr. Tak Mak, Director, The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital (PMH), has discovered a new aspect of "metabolic transformation", the process whereby tumour cells adapt and survive under conditions that would kill normal cells.
Breast cancer survivors at higher risk for fracturesThe combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors, revealed by researchers in a study.
Hormone therapy at menopause may lead to breast cancerHormone therapy around menopause is linked to breast cancer risk, revealed by researchers in a study published in The Journal of the National Cancer Institute.
New risk factor for developing breast cancerAn Australian research team from the Peter MacCallum Cancer Centre, the University of Melbourne and the University of Queensland has identified a new risk factor for developing breast cancer. This has been published online in the journal Cancer Prevention Research.
Cancer risk found for long-term hormone therapyUsing postmenopausal hormone therapy for more than 15 years increases a woman's risk of developing breast cancer, particularly among leaner women according to research at the Keck School of Medicine of the University of Southern California (USC).
Cleaning products may cause breast cancerWomen who report greater use of cleaning products may be at higher breast cancer risk than those who say they use them sparingly, revealed by researchers in a new study.
Exercise may keep cancer patients healthierBreast and prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued, according to researchers at Henry Ford Hospital in Detroit.
Gene test identifies subtypes of breast cancerA simple genetic test that uses just three genes is among the most effective means of classifying breast cancer into sub-types, US researchers report at the IMPAKT Breast Cancer Conference in Brussels, Belgium.
Sulforaphane in broccoli may limit breast cancer cellsA compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells -- the small number of cells that fuel a tumor's growth -- according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
Genomic sequencing of difficult breast cancersLife Technologies Corporation (NASDAQ: LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies.
Pomegranates may prevent breast cancer growthEating fruit, such as pomegranates, that contain anti aromatase phytochemicals reduces the incidence of hormone-dependent breast cancer, according to results of a study published in the January issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.
Herceptin with chemotherapy improves breast cancer survivalUsing Herceptin with chemotherapy clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher.
Caution about mammography use among women younger than 40 yearsBreast cancer screening guidelines generally recommend mammography begin at age 40. However, based on prior national research, an estimated 34 percent of non-Hispanic black women, 30 percent of non-Hispanic white women and 22 percent of Hispanic women aged 30 to 39 have reported having a mammogram.
Soy food lowers breast cancer recurrenceAlthough there is a concern regarding the safety of soy food consumption among breast cancer survivors, researchers have found that women in China who had breast cancer and a higher intake of soy food had an associated lower risk of death and breast cancer recurrence.
Isolation and stress contribute to breast cancer riskSocial isolation and related stress could contribute to human breast cancer susceptibility, research from a rat model designed at the University of Chicago to identify environmental mechanisms contributing to cancer risk shows.
Less hormone therapy use in women reduced breast cancer rateThe decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.
Breast cancer recurrence high in women with dense breastsWomen treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts, revealed by researchers in a study published in the Cancer -- journal of the American Cancer Society.
Exercise reduces breast cancer riskPost-menopausal women who engage in moderate to vigorous exercise and physical activity have a reduced risk of breast cancer, revealed by researchers. Breast cancer is recognized as the most common cancer affecting US women.
Social interaction or isolation affects breast cancerSocial environment can play an important role in the biology of disease, including breast cancer, and lead to significant differences in health outcome, revealed by researchers.
Obesity, alcohol use and smoking increase second breast cancer riskObesity, alcohol use and smoking significantly increase the risk of second breast cancer among breast cancer survivors, revealed by researchers at the Fred Hutchinson Cancer Research Center.
Breastfeeding reduces risk of breast cancerWomen with a family history of breast cancer were 59 percent less likely to develop breast cancer themselves if they breastfed their children, revealed by US researchers.
Women opt surgery to remove breasts, ovaries to reduce cancer riskMany women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, revealed by US researchers.
Breast cells responsible for breast cancersBreast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1, revealed by researchers.
Breast cancer drug Abraxane promising for malignant melanoma treatmentAn approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers.
Routine MRI scan to evaluate breast cancer is challengedWomen with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment, revealed by researchers.
Breast cancer gene responds to blood pressure drug in labResearchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug, according to a new study from the University of Michigan Comprehensive Cancer Center.
Low income breast cancer patients skipping hormonal therapyMany low-income women are failing to take the hormonal therapy prescribed as part of their breast cancer treatment, possibly lowering their survival rates, according to a study led by a researcher in the Duke Comprehensive Cancer Center.
$5.9 million grant for breast cancer researchRichard Junghans, MD, associate professor of surgery at Boston University School of Medicine (BUSM) and Chief of Surgical Research was named principal investigator of a grant to research how breast cancer patients' own cells can be modified to fight their disease.
Walnuts may prevent breast cancerWalnut consumption may provide the body with essential omega-3 fatty acids, antioxidants and phytosterols that reduce the risk of breast cancer, according to a study presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Aggressive breast cancer risk higher for black womenLifestyle, age and weight have all been considered as risk factors for breast cancer. Now a study published in the open access journal Breast Cancer Research has found that even taking these factors into consideration, black women face three times the risk of developing an aggressive 'triple negative tumour' compared to women of other racial backgrounds.
$10.5 million pledge for breast cancer researchBoston University School of Medicine (BUSM) has received a pledge of $10.5 million to create a Breast Cancer Research Center, including an assistant professorship and an international scholars training program, from a Boston University School of Medicine graduate who wishes to remain anonymous. This pledge represents the largest individual gift received by the School of Medicine.
Women with BRCA mutation most likely to undergo mastectomyWomen at increased risk for breast cancer because of the genetic BRCA mutations are more likely to think a prophylactic mastectomy is the best way to reduce their risk for the disease, compared to other women who are at high risk, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Naomi Campbell opens Breakthrough Breast Cancer research unit, UKSupermodel Naomi Campbell opened Breakthrough Breast Cancer's new London research unit dedicated to finding treatments for an aggressive type of breast cancer.
New genomic test to personalize breast cancer treatmentA set of 50 genes can be used to reliably identify the four known types of breast cancer, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.
Pregnancy has no impact on breast cancer diagnosis and treatmentYoung women who develop breast cancer during their pregnancy, or who are diagnosed within one year of their pregnancy, have no difference in rates of local recurrence, distant metastases and overall survival compared to other young women with the disease, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Preventive mastectomy decision for breast cancer patientA preventive procedure to remove the unaffected breast in breast cancer patients with disease in one breast may only be necessary in patients who have high-risk features as assessed by examining the patient's medical history and pathology of the breast cancer, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Olivia Newton John appeals to support breast cancer researchGrease star and cancer campaigner Olivia Newton-John is returning to her Cambridge roots on Wednesday 14 January when she visits Addenbrooke's Hospital to find out about the latest research into breast cancer.
Laura Bush's partnership for breast cancer awareness in PanamaThe University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian Fernández de Torrijos, the First Lady of Panama.
$19 Million to M. D. Anderson for breast cancer researchThe University of Texas M. D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure® as part of that organization's new initiative to fast-track promising research to benefit breast cancer patients.
Mammograms read by computers will boost cancer detectionA computer can safely replace a medical expert in a revolutionary way of interpreting a breast X-ray – according to a Cancer Research UK funded study.
23andMe announces breast cancer initiative23andMe, Inc., the industry leader in personal genetics, announced that it is embarking on a world-wide effort to assemble the largest cohort of women whose lives have been impacted by breast cancer and to build an infrastructure, based on genetics, that will accelerate consumer-based research of the disease.
Breastfeeding mothers reduce breast cancer riskMothers who breastfeed their babies for a total of a year, are almost five per cent less likely to develop breast cancer than women who do not breastfeed at all, a scientist has advised.
Birth size is a marker of breast cancer susceptibilityBirth size, and in particular birth length, correlates with subsequent risk of breast cancer in adulthood, according to a new study published in PLoS Medicine by researchers at the London School of Hygiene and Tropical Medicine.
Breast cancer mammograms benefit women up to the age of 75Breast cancer screening is effective, appropriate and reduces deaths from the disease in women aged up to 75 years old according to new research in over 860,000 women aged 70-75 presented at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.
Short radiotherapy benefits breast cancer patientsA lower total dose of radiotherapy, delivered in fewer, larger treatments has been shown to be as effective as the international standard of a higher total dose delivered over a longer time to treat women with early breast cancer – according to new research published in the Lancet and Lancet Oncology today.
1 in 20 breast cancer web pages features inaccuraciesIn an extended analysis of Web pages dedicated to disseminating breast cancer information, researchers at two University of Texas institutions in Houston have determined that while most breast cancer data found online was accurate, one in 20 breast cancer Web pages featured inaccuracies and sites displaying complementary and alternative medicine were 15 times more likely to contain false or misleading health information.
Black women get breast cancer two decades earlier than white womenBlack British women in Hackney, East London, are diagnosed with breast cancer 21 years younger than white British women, according to a Cancer Research UK study published online in the British Journal of Cancer.
Combined hormone therapy increases lobular breast cancer riskPostmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.
Breast cancer gene mutation common in Hispanic, young black womenA genetic mutation already known to be more common in Ashkenazi Jewish breast cancer patients is also prevalent in Hispanic and young African-American women with breast cancer, according to one of the largest, multiracial studies of the mutation to date.
New perspectives on health disparities in breast cancer researchBreast cancer is a disease with a number of known genetic and behavioral risk factors, but scientists have seen that these risks are often compounded by social and racial inequalities. The question remains: how, exactly, do social disadvantages, genetics, race and culture add to the disparities faced by so many groups of women?
57 Breast Cancer Research articles listed above.